The Globe and Mail reports in its Thursday edition that retail investors are piling into big-name cannabis companies such as Tilray and Canopy Growth all over again, forcing some analysts to throw in the towel on valuing the sector.
The Globe's Tim Kiladze writes that CIBC World Markets analyst John Zamparo says, "Fundamental factors are moot in the current market, which is reminiscent of other euphoric times in the cannabis industry." When marijuana stocks took off in early 2018, direct investing platforms run by major Canadian banks experienced widespread outages and glitches because of unprecedented retail trading volumes for cannabis shares.
Such traders appear to be rushing back to the sector, lighting up Reddit boards and increasing trading volatility. The difference during the early stages of this rally is that investors have been more likely to buy shares of individual cannabis companies than the Horizons Marijuana Life Sciences Index ETF, which tracks the industry's stocks.
The recent surge in enthusiasm makes weed companies tough to value -- at least according to traditional models.
American day traders may also be behind the surge, since they do not have many options for playing the market.
© 2022 Canjex Publishing Ltd. All rights reserved.